FSD Pharma Inc. (HUGE)
FSD Pharma Statistics
Share Statistics
FSD Pharma has 741.61K shares outstanding. The number of shares has increased by -98.17% in one year.
| Shares Outstanding | 741.61K |
| Shares Change (YoY) | -98.17% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 0% |
| Shares Floating | 600.7K |
| Failed to Deliver (FTD) Shares | 36.03K |
| FTD / Avg. Volume | 18.37% |
Short Selling Information
The latest short interest is 176.97K, so 0.38% of the outstanding shares have been sold short.
| Short Interest | 176.97K |
| Short % of Shares Out | 0.38% |
| Short % of Float | 0.44% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -127.5 and the forward PE ratio is null. FSD Pharma's PEG ratio is 5.88.
| PE Ratio | -127.5 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 179.74 |
| P/FCF Ratio | -214.06 |
| PEG Ratio | 5.88 |
Enterprise Valuation
FSD Pharma has an Enterprise Value (EV) of 2.36B.
| EV / Sales | 0 |
| EV / EBITDA | -136.08 |
| EV / EBIT | -214.46 |
| EV / FCF | -213.84 |
Financial Position
The company has a current ratio of 2.43, with a Debt / Equity ratio of 0.02.
| Current Ratio | 2.43 |
| Quick Ratio | 2.43 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | -0.02 |
| Debt / FCF | -0.03 |
| Interest Coverage | -65451.89 |
Financial Efficiency
Return on Equity is -140.97% and Return on Invested Capital is -147.96%.
| Return on Equity | -140.97% |
| Return on Assets | -106.78% |
| Return on Invested Capital | -147.96% |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-1.09M |
| Employee Count | 17 |
| Asset Turnover | 0 |
| Inventory Turnover | 1.28M |
Taxes
| Income Tax | -1 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -99.72% in the last 52 weeks. The beta is 0.85, so FSD Pharma's price volatility has been higher than the market average.
| Beta | 0.85 |
| 52-Week Price Change | -99.72% |
| 50-Day Moving Average | 6.86 |
| 200-Day Moving Average | 34.82 |
| Relative Strength Index (RSI) | 39.33 |
| Average Volume (20 Days) | 196.16K |
Income Statement
| Revenue | n/a |
| Gross Profit | -2.55M |
| Operating Income | -19.93M |
| Net Income | -18.56M |
| EBITDA | -17.38M |
| EBIT | -18.56M |
| Earnings Per Share (EPS) | -0.47 |
Balance Sheet
The company has 2.74M in cash and 337.46K in debt, giving a net cash position of 2.41M.
| Cash & Cash Equivalents | 2.74M |
| Total Debt | 337.46K |
| Net Cash | 2.41M |
| Retained Earnings | -157.1M |
| Total Assets | 15.42M |
| Working Capital | 5.26M |
Cash Flow
In the last 12 months, operating cash flow was -11.03M and capital expenditures -31.78K, giving a free cash flow of -11.06M.
| Operating Cash Flow | -11.03M |
| Capital Expenditures | -31.78K |
| Free Cash Flow | -11.06M |
| FCF Per Share | -0.28 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HUGE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -0.78% |
| FCF Yield | -0.47% |
Analyst Forecast
Currently there are no analyst rating for HUGE.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Oct 16, 2019. It was a backward split with a ratio of 1:201.
| Last Split Date | Oct 16, 2019 |
| Split Type | backward |
| Split Ratio | 1:201 |
Scores
| Altman Z-Score | -16.79 |
| Piotroski F-Score | 2 |